Navigation Links
Acumed Signs Agreement with Vivorte to Distribute its Orthobiologics Portfolio
Date:3/13/2020

Acumed LLC today announced that it has entered into an agreement with Vivorte Inc. to be the exclusive distributor of the Louisville-based company’s orthobiologics portfolio. Under the terms of the agreement, Acumed will employ its sales, marketing, and medical education expertise to distribute Vivorte’s calcium phosphate-based bone allograft (Trabexus) and calcium phosphate-based biocement (Fortera). Vivorte will continue to utilize its product development and manufacturing capabilities to support the distribution.

“As a leader in the orthopaedic sector, Acumed is committed to providing the most comprehensive clinical solutions to our surgeons and this partnership with Vivorte allows us to deliver a best-in-class portfolio of orthobiologic technologies,” said Jagi Gill, Vice President/General Manager of AcuVentures at Acumed. “The Trabexus and Fortera products provide our surgeons the distinguishing features of ease of use, strength, and remodeling that are requisite in premier bone allografts and bone void fillers.”

The Trabexus product line is a self-setting calcium phosphate matrix with engineered allograft bone particles for optimized compressive strength and resorptive characteristics. Fortera is an osteoconductive biocement that combines industry leading compressive strength with superior flow characteristics. In the US alone, the orthobiologics market is estimated to be in excess of $550 million, of which the synthetic allograft market occupies a significant and growing segment.

Mark Wagner, CEO of Vivorte, commented, “We have been pleased with the strong clinical support and adoption of our products in the market. Partnering with Acumed, we will reach more surgeons to the benefit of more patients, thereby extending the commercial footprint for our orthobiologic technologies. This works because the two companies share a common vision of delivering innovative solutions in a quality-first culture.”

About Acumed
Acumed is a global leader in developing innovative orthopaedic and medical solutions to improve patient care. Acumed has more than three decades of experience in the orthopaedic industry, with the mission of aiding the afflicted through the ingenuity of our minds, the labor of our hands, and the compassion of our hearts. Founded in 1988, Acumed is headquartered in Hillsboro, Oregon, with offices and a distribution network around the world. For more information, visit http://www.acumed.net.

Read the full story at https://www.prweb.com/releases/acumed_signs_agreement_with_vivorte_to_distribute_its_orthobiologics_portfolio/prweb16973753.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology news :

1. Encouraging signs for bee biodiversity
2. Light and nanoprobes detect early signs of infection
3. Fluke Biomedical launches portable, feature-rich ProSim 3 and 2 Vital Signs Simulators
4. Leopoldina signs cooperation agreement with the Academy of Science of South Africa
5. BioClaim, Inc. Signs Biometric Software Contract with Amerigroup Florida
6. Switzerland signs the ELIXIR consortium agreement and contributes €35 million
7. Research reveals new understanding, warning signs, and potential treatments for multiple sclerosis
8. A*STAR signs agreement with Nestlé to strengthen food & nutrition R&D in Singapore
9. Quick test finds signs of diarrheal disease
10. Small non-coding RNAs could be warning signs of cancer
11. ARUP Labs signs agreement with UH Case Medical Center to distribute novel DEEPGEN HIV test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2020)... ... March 04, 2020 , ... ... to apply to the MedTech IGNITE program’s 2020 IGNITE Cohort. The MedTech IGNITE ... to attract and nurture the next generation of medtech founders and entrepreneurs. IGNITE ...
(Date:3/3/2020)... ... , ... Amplify Surgical, Inc., today announces that the company reached the milestone ... , The landmark case was performed by Dr. Ali Najafi at Fresno Heart and ... completely changed the game for expandable interbodies. The ability to achieve an ALIF ...
(Date:3/2/2020)... ... ... Philadelphia IP law firm Panitch Schwarze Belisario & Nadel LLP is pleased to announce ... Stephany G. Small, Ph.D., has joined the firm as a patent agent. ... firm’s biotechnology and life science practice group. He has significant experience with domestic and ...
Breaking Biology News(10 mins):
(Date:3/19/2020)... ... March 17, 2020 , ... ... manufacturing collaboration agreement with pioneering gene circuit company Senti Biosciences, Inc. (Senti) ... cancer and other solid tumor indications. The collaboration will leverage RoosterBio’s human ...
(Date:3/10/2020)... ... March 10, 2020 , ... Ortho Clinical Diagnostics, a global leader of in ... ORTHOTM Sera, ID-MTS, a suite of extended antigen in a gel testing format used ... ORTHO VISION® and ORTHO VISION® Max in the United States and Canada. The clearances ...
(Date:3/4/2020)... ... March 04, 2020 , ... This month, Cognosante will make its ... company will showcase both expanded and emerging offerings that align with the HIMSS annual ... designed to be comprehensive, timely, and engaging. From Interoperability and HIE ...
(Date:2/28/2020)... ... February 26, 2020 , ... ... combines a high-speed camera with a dedicated controller, thus simplifying setup, streamlining integration, ... the HS7 is the first of Fastec Imaging’s new HS Series cameras to ...
Breaking Biology Technology: